Opin vísindi

Fletta eftir höfundi "Albertsen, Birgitte Klug"

Fletta eftir höfundi "Albertsen, Birgitte Klug"

Röðun: Raða: Niðurstöður:

  • Dam, Merete; Centanni, Maddalena; Friberg, Lena E.; Centanni, Daniel; Karlsson, Mats O.; Stensig Lynggaard, Line; Johannsdottir, Inga Maria; Wik, Hilde Skuterud; Malmros, Johan; Vaitkeviciene, Goda Elizabeta; Griskevicius, Laimonas; Hallböök, Helene; Jónsson, Ólafur Gísli; Overgaard, Ulrik; Schmiegelow, Kjeld; Hansen, Stefan Nygaard; Heyman, Mats; Albertsen, Birgitte Klug (2024)
    Asparaginase is an essential component of acute lymphoblastic leukemia (ALL) therapy, yet its associated toxicities often lead to treatment discontinuation, increasing the risk of relapse. Hypersensitivity reactions include clinical allergies, silent ...
  • Egnell, Christina; Heyman, Mats; Jónsson, Ólafur Gísli; Raja, Raheel A; Niinimäki, Riitta; Albertsen, Birgitte Klug; Schmiegelow, Kjeld; Stabell, Niklas; Vaitkeviciene, Goda; Lepik, Kristi; Harila-Saari, Arja; Ranta, Susanna (2022-03)
    Obesity is associated with poor outcomes in childhood acute lymphoblastic leukaemia (ALL). We explored whether severe treatment-related toxicity and treatment delays could explain this observation. This study included 1 443 children aged 2·0-17·9 years ...
  • Dam, Merete; Lynggaard, Line Stensig; Jónsson, Ólafur Gísli; Saulyte Trakymiene, Sonata; Palk, Katrin; Jarvis, Kirsten; Andrés-Jensen, Liv; Tuckuviene, Ruta; Albertsen, Birgitte Klug (2024-06)
    The treatment of acute lymphoblastic leukemia (ALL) is frequently complicated by toxicity, including venous thromboembolism (VTE) affecting roughly 8% of patients. VTE can lead to post-thrombotic syndrome (PTS), a group of signs and symptoms developed ...